Efficacy of co-trimoxazole in infantile gastro-enteritis.
A comparative, randomized trial was carried out in 105 children, aged between 2 months and 2 years and who were suffering from acute gastro-enteritis, to assess the effectiveness of co-trimoxazole with that of streptomycin and neomycin. Patients were treated in hospital for 5 days or longer and received daily doses either of 50 mg/kg streptomycin or neomycin, or of 6 mg trimethoprim plus 30 mg sulphamethoxazole/kg. Clinical and bacteriological assessments of response to treatment showed that better results were achieved in the co-trimoxazole group, and the duration of illness was also shorter in this this group. In the 3 patients on neomycin and the 12 on streptomycin who did not respond clinically, symptoms were controlled in all of them within 2 to 3 days of being changed over to co-trimoxazole treatment.